# Mau Ern Poh

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/mau-ern-poh/

## Facts

| Field | Value |
| --- | --- |
| Citations | 828 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 12 |
| i10-index | 16 |
| Last Known Institution | University of Malaya |
| OpenAlex ID | https://openalex.org/A5068676008 |
| ORCID iD | 0000-0003-0971-2795 |
| Works | 62 |

## Researcher papers

- [Integrative microbiomics in bronchiectasis exacerbations](https://scholariq.org/papers/integrative-microbiomics-in-bronchiectasis-exacerbations/)
- [Environmental fungal sensitisation associates with poorer clinical outcomes in COPD](https://scholariq.org/papers/environmental-fungal-sensitisation-associates-with-poorer-clinical-outcomes-in/)
- [A high-risk airway mycobiome is associated with frequent exacerbation and mortality in COPD](https://scholariq.org/papers/a-high-risk-airway-mycobiome-is-associated-with-frequent-exacerbation-and/)
- [High Frequency of Allergic Bronchopulmonary Aspergillosis in Bronchiectasis-COPD Overlap](https://scholariq.org/papers/high-frequency-of-allergic-bronchopulmonary-aspergillosis-in-bronchiectasis-copd/)
- [Airway “Resistotypes” and Clinical Outcomes in Bronchiectasis](https://scholariq.org/papers/airway-resistotypes-and-clinical-outcomes-in-bronchiectasis/)
- [Epithelial-to-mesenchymal transition (EMT) causing acquired resistance to afatinib in a patient with epidermal growth factor receptor (EGFR)-mutant lung adenocarcinoma](https://scholariq.org/papers/epithelial-to-mesenchymal-transition-emt-causing-acquired-resistance-to-afatinib/)
- [Identification of GPX4 as a therapeutic target for lung adenocarcinoma after EGFR-TKI resistance](https://scholariq.org/papers/identification-of-gpx4-as-a-therapeutic-target-for-lung-adenocarcinoma-after/)
- [Sensitisation to recombinant<i>Aspergillus fumigatus</i>allergens and clinical outcomes in COPD](https://scholariq.org/papers/sensitisation-to-recombinant-i-aspergillus-fumigatus-i-allergens-and-clinical/)
- [Triptolide inhibits epithelial-mesenchymal transition phenotype through the p70S6k/GSK3/β-catenin signaling pathway in taxol-resistant human lung adenocarcinoma](https://scholariq.org/papers/triptolide-inhibits-epithelial-mesenchymal-transition-phenotype-through-the/)
- [Accuracy of lung cancer staging in the multidisciplinary team setting](https://scholariq.org/papers/accuracy-of-lung-cancer-staging-in-the-multidisciplinary-team-setting/)
- [Resistance mechanisms causing first-line epidermal growth factor receptor-tyrosine kinase inhibitor treatment failure](https://scholariq.org/papers/resistance-mechanisms-causing-first-line-epidermal-growth-factor-receptor/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Chronic Obstructive Pulmonary Disease (COPD) Research](https://scholariq.org/topics/chronic-obstructive-pulmonary-disease-copd-research/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Cystic Fibrosis Research Advances](https://scholariq.org/topics/cystic-fibrosis-research-advances/)

## Researcher university

- [University of Malaya](https://scholariq.org/institutions/university-of-malaya/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.